Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gimeracil (1 trial)
oteracil (1 trial)
s-1 (1 trial)
tegafur (1 trial)
Pancreatic Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (4 total)